Affinity Asset Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Affinity Asset Advisors’s Portfolio CRSP Stock Details CRSP Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.14M	Buy
2025 Q3	–	Hold
2025 Q2	–	Hold
2024 Q2	–	Hold
2024 Q1	–	Hold
2022 Q3	–	Hold
2022 Q2	–	Hold
2022 Q1	–	Hold
2021 Q1	–	Sell
2020 Q4	$536K	Buy